Andres Maldonado Analyst Performance

Analyst at HC Wainwright

Andres Maldonado is a stock analyst at HC Wainwright in the medical sector, covering 11 publicly traded companies. Over the past year, Andres Maldonado has issued 16 stock ratings, including and buy recommendations. While full access to Andres Maldonado's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Andres Maldonado's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 16 Last 0 Years
Buy Recommendations: 100.00% 16 Buy Ratings
Companies Covered: 11 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	100.0%	16 ratings
Hold	0.0%	0 ratings
Sell	0.0%	0 ratings

the majority (100.0%) have been Buy recommendations.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	100.0% of companies on NASDAQ	11 companies

Andres Maldonado, an analyst at HC Wainwright, currently covers 11 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 11 companies	100.0%

Andres Maldonado of HC Wainwright specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 9 companies	81.8%
MED - DRUGS 2 companies	18.2%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
IMAB I-Mab	7/9/2025	Reiterated Rating	$2.20	$7.00	Buy
AURA Aura Biosciences	5/28/2025	Upgrade	$5.99	$22.00	Buy
ZNTL Zentalis Pharmaceuticals	5/15/2025	Reiterated Rating	$1.19	$10.00	Buy
TCRX TScan Therapeutics	5/7/2025	Lower Price Target	$1.36	$10.00	Buy
CRBP Corbus Pharmaceuticals	5/7/2025	Lower Price Target	$6.25	$40.00	Buy
ERAS Erasca	4/30/2025	Reiterated Rating	$1.43	$6.00	Buy
FHTX Foghorn Therapeutics	4/30/2025	Reiterated Rating	$4.25	$13.00	Buy
TARA Protara Therapeutics	4/28/2025	Reiterated Rating	$4.32	$23.00	Buy
CGON CG Oncology	4/28/2025	Reiterated Rating	$22.37	$75.00	Buy
DAWN Day One Biopharmaceuticals	4/3/2025	Reiterated Rating	$7.97	$36.00	Buy
CGON CG Oncology	3/31/2025	Reiterated Rating	$26.42	$75.00	Buy
CGON CG Oncology	3/25/2025	Reiterated Rating	$28.53	$75.00	Buy
ERAS Erasca	3/21/2025	Reiterated Rating	$1.48	$6.00	Buy
CRBP Corbus Pharmaceuticals	3/12/2025	Reiterated Rating	$6.88	$50.00	Buy
HOWL Werewolf Therapeutics	3/12/2025	Reiterated Rating	$1.26	$15.00	Buy
DAWN Day One Biopharmaceuticals	2/26/2025	Lower Price Target	$11.82	$36.00	Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.